Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For BRAGF
Valuation Weak
14%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Weak
17%
Per Share Metrics n.A.
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q1 Q2 Δ in %
Current Ratio -4.21 1.26 1.32
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 121.75 15.38 6.94
Naive Interpretation member
2 Per Share
Metric Q1 Q2 Δ in %
Book Value inf 0.00 18.13
Cash inf 0.00 2.52
Capex inf 0.00 -1.06
Free Cash Flow inf 0.00 -3.23
Revenue inf 0.00 16.92
Naive Interpretation member
3 Profitability
Metric Q1 Q2 Δ in %
Gross Margin -5.21 0.46 0.48
Operating Margin -27.76 0.07 0.10
ROA -37.04 < 0.005 < 0.005
ROE -38.23 < 0.005 < 0.005
ROIC -27.45 0.01 0.01
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of BRAGF is permitted for members.
5 Growth
The "Growth Entry" for the Focus of BRAGF is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of BRAGF is permitted for members.